Evidence map›Paper›PMID 29084984›Full record

ArticleScientific reports2017

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Sung-Hsin Kuo, Kun-Huei Yeh, Ming-Shiang Wu, Chung-Wu Lin, Ming-Feng Wei, Jyh-Ming Liou, Hsiu-Po Wang, Li-Tzong Chen, Ann-Lii Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Role of non-World journal of gastroenterology · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Clinical case reports · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Cytotoxin-Associated Gene A-PositiveThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sung-Hsin KuoDepartment of Oncology, National Taiwan University, Taipei, Taiwan.ORCID 0000-0003-0054-887X
Kun-Huei YehDepartment of Oncology, National Taiwan University, Taipei, Taiwan.
Ming-Shiang WuDepartment of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Chung-Wu LinDepartment of Pathology, National Taiwan University, Taipei, Taiwan.
Ming-Feng WeiDepartment of Oncology, National Taiwan University, Taipei, Taiwan.
Jyh-Ming LiouDepartment of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Hsiu-Po WangDepartment of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Li-Tzong ChenNational Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Ann-Lii ChengDepartment of Oncology, National Taiwan University, Taipei, Taiwan. alcheng@ntu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

First-line antibiotic treatment for eradicating Helicobacter pylori (HP) infection is effective in HP-positive low-grade gastric mucosa-associated lymphoid tissue lymphoma (MALToma), but its role in HP-negative cases is uncertain. In this exploratory retrospective study, we assessed the outcome and potential predictive biomarkers for 25 patients with HP-negative localized gastric MALToma who received first-line HP eradication (HPE) therapy. An HP-negative status was defined as negative results on histology, rapid urease test,

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsAntineoplastic AgentsB-Cell CLL-Lymphoma 10 ProteinDrug Resistance, NeoplasmFemaleGastric MucosaGene Expression Regulation, NeoplasticHelicobacter pyloriHumansLymphoid TissueLymphomaMaleMiddle AgedAnti-Bacterial AgentsAntineoplastic AgentsB-Cell CLL-Lymphoma 10 ProteinBCL10 protein, humanNF-kappa B

Identifiers

PMID29084984
PMCPMC5662601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.